REPORT ID 2487

China Ophthalmology Drugs Market Research Report 2017

Publish Date
8-Dec-17
Pages
95
Format
Electronic (PDF)

The global Ophthalmology Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Ophthalmology Drugs development status and future trend in China, focuses on top players in China, also splits Ophthalmology Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Novartis
    Regeneron
    Roche
    Bayer
    Allergan
    Shire
    Mallinckrodt
    ...

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
    Lucentis (ranibizumab)
    Eylea (aflibercept)
    Avastin (bevacizumab)
    Restasis (cyclosporine)
    Alphagan (brimonidine tartrate)
    Lumigan (bimatoprost)
    Xalatan (latanoprost

On the basis of the end users/application, this report covers
    Chorioretinitis
    Choroiditis
    Retinitis
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Ophthalmology Drugs Market Research Report 2017
1 Ophthalmology Drugs Overview
    1.1 Product Overview and Scope of Ophthalmology Drugs
    1.2 Classification of Ophthalmology Drugs by Product Category
        1.2.1 China Ophthalmology Drugs Sales (K Pcs) Comparison by Type (2012-2022)
        1.2.2 China Ophthalmology Drugs Sales (K Pcs) Market Share by Type in 2016
        1.2.3 Lucentis (ranibizumab)
        1.2.4 Eylea (aflibercept)
        1.2.5 Avastin (bevacizumab)
        1.2.6 Restasis (cyclosporine)
        1.2.7 Alphagan (brimonidine tartrate)
        1.2.8 Lumigan (bimatoprost)
        1.2.9 Xalatan (latanoprost
    1.3 China Ophthalmology Drugs Market by Application/End Users
        1.3.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Chorioretinitis
        1.3.3 Choroiditis
        1.3.4 Retinitis
        1.3.5 Others
    1.4 China Ophthalmology Drugs Market by Region
        1.4.1 China Ophthalmology Drugs Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Ophthalmology Drugs Status and Prospect (2012-2022)
        1.4.3 East China Ophthalmology Drugs Status and Prospect (2012-2022)
        1.4.4 Southwest China Ophthalmology Drugs Status and Prospect (2012-2022)
        1.4.5 Northeast China Ophthalmology Drugs Status and Prospect (2012-2022)
        1.4.6 North China Ophthalmology Drugs Status and Prospect (2012-2022)
        1.4.7 Central China Ophthalmology Drugs Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Ophthalmology Drugs (2012-2022)
        1.5.1 China Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%)(2012-2022)
        1.5.2 China Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Ophthalmology Drugs Market Competition by Players/Manufacturers
    2.1 China Ophthalmology Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Ophthalmology Drugs Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Ophthalmology Drugs Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
    2.4 China Ophthalmology Drugs Market Competitive Situation and Trends
        2.4.1 China Ophthalmology Drugs Market Concentration Rate
        2.4.2 China Ophthalmology Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Ophthalmology Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 China Ophthalmology Drugs Sales and Revenue by Region (2012-2017)
    3.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
    3.2 China Ophthalmology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Ophthalmology Drugs Price (USD/Pcs) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Ophthalmology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Ophthalmology Drugs Price (USD/Pcs) by Type (2012-2017)
    4.4 China Ophthalmology Drugs Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Ophthalmology Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
    5.2 China Ophthalmology Drugs Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Ophthalmology Drugs Players/Suppliers Profiles and Sales Data
    6.1 Novartis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ophthalmology Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Regeneron
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Ophthalmology Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Regeneron Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Roche
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Ophthalmology Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Roche Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bayer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Ophthalmology Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bayer Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Allergan
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Ophthalmology Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Allergan Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shire
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Ophthalmology Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shire Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Mallinckrodt
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Ophthalmology Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Mallinckrodt Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Ophthalmology Drugs Manufacturing Cost Analysis
    7.1 Ophthalmology Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ophthalmology Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ophthalmology Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Ophthalmology Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Ophthalmology Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    11.3 China Ophthalmology Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 China Ophthalmology Drugs Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List